ESSA Pharma Inc.

ESSA Pharma Inc.: In Ph1b with a small molecule drug targeting the n-terminal domain of the androgen receptor. Potential for treatment post-current AR therapies and in combination in earlier lines. Pfizer participated in most recent fundraising. Recent collaborations with Bayer, Astellas, and Janssen to evaluate combinations with their main drug candidate EPI-7386.
Based in...
North America
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Disease Space
Men's Health, Oncology
Public, USA
Market Cap
100MM - 500MM
999 West Broadway Street Suite 720
Vancouver, BC BC V5Z 1K5

Company Participants at Solebury Trout Hamptons CEO Roundtable 2021

  • David Parkinson, President/CEO

Top 10 Holders of ESSA Pharma Inc

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Bellevue Asset Management AG 11.40 5,015,814 45.39 Stakes 8/18/21
Clarus Ventures LLC 8.16 3,303,103 29.89 13F 6/30/21
RTW Investments LP 7.55 3,053,919 27.64 13F 6/30/21
Avidity Partners Management LP 6.80 2,750,000 24.89 13F 6/30/21
BVF, Inc. 6.06 2,451,561 22.19 13F 6/30/21
Eventide Asset Management LLC 5.95 2,405,169 21.77 13F 6/30/21
Soleus Capital Management LP 5.53 2,238,104 20.25 13F 6/30/21
Janus Capital Management LLC 4.99 2,017,894 18.26 13F 6/30/21
Vivo Capital LLC 3.84 1,551,680 14.04 13F 6/30/21
Adage Capital Partners GP LLC 3.34 1,350,000 12.22 13F 6/30/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.